Document ID: chunk:federal_register_of_legislation:F2024C01086:clause:1_12315
Version: federal_register_of_legislation:F2024C01086
Segment Type: clause
Provision Reference: sch 1 cl 12315
Character Range: 799635–801137

12315                                                            Bone densitometry, using dual energy X‑ray absorptiometry, involving the measurement of 2 or more sites (including interpretation and reporting) for diagnosis and monitoring of bone loss associated with one or more of the following conditions:                                                                                                                                                                                                                                                                                                                         106.55
                                                                 (a) primary hyperparathyroidism;
                                                                 (b) chronic liver disease;
                                                                 (c) chronic renal disease;
                                                                 (d) any proven malabsorptive disorder;
                                                                 (e) rheumatoid arthritis;
                                                                 (f) any condition associated with thyroxine excess;
                                                                 other than a service associated with a service to which item 12306, 12312 or 12321 applies
                                                                 For any particular patient, once only in a 24 month period